Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Belldegrun

Showing results (31-40 of 126) with videos related to

Pageof 13
Sort By:
The Israel Medical Association Journal : IMAJ|July 13, 2000
Gene and immune-based therapies for genitourinary malignancies: current status and future prospectsA Zisman, A J Pantuck, A Belldegrun
Cancer Research|January 1, 1988
Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activityA Belldegrun, L M Muul, S A Rosenberg
Seminars in Oncology|February 1, 1995
Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinomaW C Pierce, A Belldegrun, R A Figlin
Seminars in Urologic Oncology|November 1, 1996
Immunotherapy and gene therapyB J Gitlitz, A Belldegrun, R A Figlin
Cancer Investigation|January 1, 1995
Immunologic approaches to the treatment of cancerR A Figlin, B J Gitlitz, A Belldegrun
Seminars in Urology|February 1, 1992
Immunotherapy for renal cell carcinomaA Belldegrun, R Figlin, J Danella, et al.
Seminars in Oncology|December 1, 1993
Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinomaR A Figlin, W C Pierce, A Belldegrun
Urology|October 1, 1986
Use of surgical stapler in adrenal surgeryG P Kearney, C J Doyle, A Belldegrun
Cellular Immunology|August 25, 1997
Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicityP Frost, C P Ng, A Belldegrun, et al.
The Journal of Urology|March 1, 1982
Late appearance of parathyroid adenoma in a renal transplant recipient with multiple primary malignanciesA Belldegrun, C Servadio, I Nissenkorn, et al.
Pageof 13

Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
The Israel Medical Association Journal : IMAJ|July 13, 2000
Gene and immune-based therapies for genitourinary malignancies: current status and future prospectsA Zisman, A J Pantuck, A Belldegrun
Cancer Research|January 1, 1988
Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activityA Belldegrun, L M Muul, S A Rosenberg
Seminars in Oncology|February 1, 1995
Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinomaW C Pierce, A Belldegrun, R A Figlin
Seminars in Urologic Oncology|November 1, 1996
Immunotherapy and gene therapyB J Gitlitz, A Belldegrun, R A Figlin
Cancer Investigation|January 1, 1995
Immunologic approaches to the treatment of cancerR A Figlin, B J Gitlitz, A Belldegrun
Seminars in Urology|February 1, 1992
Immunotherapy for renal cell carcinomaA Belldegrun, R Figlin, J Danella, et al.
Seminars in Oncology|December 1, 1993
Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinomaR A Figlin, W C Pierce, A Belldegrun
Urology|October 1, 1986
Use of surgical stapler in adrenal surgeryG P Kearney, C J Doyle, A Belldegrun
Cellular Immunology|August 25, 1997
Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicityP Frost, C P Ng, A Belldegrun, et al.
The Journal of Urology|March 1, 1982
Late appearance of parathyroid adenoma in a renal transplant recipient with multiple primary malignanciesA Belldegrun, C Servadio, I Nissenkorn, et al.
Pageof 13